Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

ADC Therapeutics (ADCT) Gross Profit (2020 - 2026)

ADC Therapeutics has reported Gross Profit over the past 7 years, most recently at $7.3 million for Q1 2026.

  • Quarterly results put Gross Profit at $7.3 million for Q1 2026, up 231.91% from a year ago — trailing twelve months through Mar 2026 was $15.5 million (up 5.03% YoY), and the annual figure for FY2022 was -$4.6 billion, down 15807.32%.
  • Gross Profit reached $7.3 million in Q1 2026 per ADCT's latest filing, up from $5.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $69.3 billion in Q4 2022 and bottomed at -$5.6 million in Q1 2025.
  • Median Gross Profit over the past 5 years was $7.3 million (2024), compared with a mean of $5.0 billion.
  • The largest annual shift saw Gross Profit surged 9101.37% in 2022 before it tumbled 183.34% in 2025.
  • Over 5 years, Gross Profit stood at $69.3 billion in 2022, then plummeted by 100.0% to $763000.0 in 2023, then skyrocketed by 862.39% to $7.3 million in 2024, then tumbled by 31.06% to $5.1 million in 2025, then soared by 44.71% to $7.3 million in 2026.
  • Business Quant data shows Gross Profit for ADCT at $7.3 million in Q1 2026, $5.1 million in Q3 2025, and $8.7 million in Q2 2025.